Pharma-Bio Serv reports Q2 2026 revenue of $2.7M, net income of $0.2M

Pharma-Bio Serv posted revenues of $2.7 million for the three months ended April 30, 2026, up $0.3 million year-over-year, with net income increasing $0.1 million to $0.2 million. The compliance and regulatory consulting firm attributed improved profitability to strategic market focus and disciplined cost management.